Press Releases

New multiline insurance solution offers up to $2.5 billion in coverage across construction and operations for utility and digital infrastructure clientsDUBLIN, Sept. 28, 2026 /CNW/ -- Aon plc (NYSE:AON), a leading global professional services firm, today announced the launch of its Power Lifecycle Program (PLP), a new integrated insurance solution designed to support conventional gas power projects from construction through testing, commissioning and into operations.Reliable power generation is becoming increasingly important as demand for digital infrastructure, cloud computing and artificial intelligence accelerates. PLP is designed to help organizations investing at scale in power generat

Tandem Diabetes Care, Inc. (NASDAQ:TNDM), a leading insulin delivery and diabetes technology company, today announced that Tandem Mobi, the world’s smallest, durable automated insulin delivery system for people living with diabetes,1 is now available in 12 countries outside the United States. The company is now taking orders and shipping to eligible customers in Belgium, the Czech Republic, Denmark, Finland, Germany, Israel, Italy, Luxembourg, Spain, Sweden, Switzerland, and the United Kingdom. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260928831177/en/Tandem Mobi, the world’s smallest, durable insulin delivery system, now s

Supply chain program spans more than 250 plants in over 30 countries Accenture (NYSE:ACN) and osapiens have worked with DS Smith, a leading international sustainable packaging company, to gain full transparency into the origin and movement of European Union Deforestation Regulation (EUDR) -relevant materials, across its Europe, Middle East, and Africa (EMEA) supply chain. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260927678573/en/Accenture and osapiens worked with DS Smith to improve supply chain transparency and establish an auditable foundation for compliance with evolving EU sustainability regulations, including the Eur

More energy, less emissions, more free cash flow TotalEnergies confirms its objectives of growth for oil, gas & electricity production and free cash flow towards 2030 and presents its ambitions for growth at 2035 horizon The Board of Directors commits to a dividend increase of more than 5% per year until 2030 and confirms a shareholder return of 40% of cash flow while deleveraging the Company 4% energy production growth per year until 2030 $10 billion free cash flow(1) growth from 2025 to 2030 at same price deck, equivalent to more than $4 per share < 10% gearing ratio anticipated by end of 2026 $2.5 billion in share buybacks in the fourth quarter of 2026 and between $2 and

NEW YORK, Sept. 28, 2026 /PRNewswire/ -- Burford Capital Limited ("Burford"), the leading global finance and asset management firm focused on law, today provides an update on a portfolio matter.  After the market close on Friday, September 25, 2026, a jury in a case in which Burford has a financial entitlement awarded $5.7 billion in damages to the plaintiff. That amount is likely to be altered in post-trial and/or appellate proceedings, but if the verdict amount were paid, as is, Burford's entitlement would be $1.4 billion, split roughly equally between Burford's balance sheet and its investment funds.Burford has elected to issue this release given media coverage of this matter that has alr

New global State of Type 2 Report uncovers three interconnected challenges in Type 2 diabetes care: health literacy, technology literacy and systemic access.1 New partnership reinforces Dexcom’s commitment to advancing Type 1 diabetes care. DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, today released its "Dexcom State of Type 2 Report: Global Access and Attitudes to Diabetes Technology" in advance of the 62nd Annual Meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy, Sept. 28-Oct. 2. The company also announced a partnership to become the official continuous glucose monitor of Team Novo Nordisk. This press release features mult

Cash and cash equivalents at €166.1 million and €67.8 million in short-term deposits1 as of June 30, 2026Cash runway guidance remains unchanged from July 30, 20262Topline results of the Phase 3 NATiV3 clinical trial are expected in the fourth quarter of 2026Key highlights from the first half of 2026 and recent Company updatesManagement to host webcast today at 8:00 AM ET to discuss first-half 2026 financial results Daix (France), New York (New York, United States), September 28, 2026 – Inventiva (NASDAQ:IVA) ("Inventiva" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of an oral therapy for the treatment of metabolic dysfunction-associated steatohep

Bloodstream infections can trigger sepsis, a life-threatening response to infection; about 1.7 million U.S. adults develop sepsis each year, contributing to at least 350,000 deaths New QIAstat-Dx test identifies 13 gram-negative bacterial targets and 18 antibiotic resistance markers in about one hour Complete QIAstat-Dx bloodstream infection menu combines two complementary panels and covers 33 pathogen targets and 28 antibiotic resistance markers QIAGEN N.V. (NYSE:QGEN, Frankfurt Prime Standard: QIA)) today announced that U.S. laboratories now have access to the complete QIAstat-Dx bloodstream infection portfolio following clearance of a new panel by the U.S. Food and Drug Admin

Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, September 28, 2026 - Addex Therapeutics (SIX and NASDAQ:ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, today reported its 2026 Half-Year and Second Quarter financial results and provided a corporate update. "The successful raising of USD 2.8 million during the last quarter enables us to continue advancing our in-house GABAB cough program towards clinical development. Coupled with recent regaining of all rights to the GABAB PAM program for substance use disorders from Indivior, due to R&D rationalization following its

SINGAPORE, Sept. 28, 2026 (GLOBE NEWSWIRE) -- VisionPower Semiconductor Manufacturing Company Pte. Ltd. (VSMC), the joint venture established in September 2024 by Vanguard International Semiconductor Corporation (VIS, TPEx: 5347) and NXP Semiconductors N.V. ((NXP, NASDAQ:NXPI), today marked the grand opening of its first 12-inch (300mm) fab in Tampines, Singapore. The opening ceremony was attended by distinguished guests, including Dr. Tan See Leng, Singapore's Minister for Trade and Industry (Energy and Industry); Mr. Png Cheong Boon, Chairman of the Singapore Economic Development Board (EDB); and Ms. Jacqueline Poh, Chief Executive Officer of JTC Corporation. Representatives from TSMC a

FF Founder and Global CEO YT Jia’s Investor Weekly Report has been rescheduled for the afternoon of September 28 and will be released at its usual time. FF has invited 10 global partners to share insights on the EAI robotics industry, FF’s "Built in USA" strategy and related topics, highlighting the potential for collaboration between global innovation resources and U.S.-based R&D, manufacturing and supply chain ecosystems. Faraday Future Intelligent Electric Inc. (NASDAQ:FFAI) ("Faraday Future," "FF," or the "Company"), a California-based global Embodied AI ("EAI") ecosystem company, today announced that this week’s Investor Weekly Report from FF Founder and Global CEO YT Jia, origi

HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Sept. 27, 2026 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited ("HUTCHMED" or the "Company") (Nasdaq/AIM:HCM; HKEX:13) today announces that it has initiated the Phase Ia part of a global clinical trial of HMPL-A830 in patients with unresectable, advanced or metastatic solid tumors. The first patient received the first dose in China on September 24, 2026. An Antibody-Targeted Therapy Conjugate ("ATTC") enables tumor-specific activity of potent, cell-killing, targeted therapy payloads by leveraging antibody-guided delivery. This first-in-class ATTC drug candidate comprises a highly selective and potent Kirsten rat sarcoma ("KRAS") small molecule i

SHANGHAI, Sept. 27, 2026 (GLOBE NEWSWIRE) -- NIO Inc. (NYSE:NIO, HKEX: 9866, SGX: NIO)) ("NIO" or the "Company"), a pioneer and a leading company in the global smart electric vehicle market, today announced the entry into definitive agreements with certain subsidiaries of Zhejiang Geely Holding Group Co., Ltd. ("Geely Holding Group") in connection with a strategic transaction in battery swapping and charging businesses. Pursuant to the definitive agreements, subject to regulatory clearances and other customary closing conditions, a subsidiary of Geely Holding Group will use (i) its holding of 100% of the equity interest of Yiyi Internet Technology (Chongqing) Co., Ltd., a subsidiary of Ge

Premium material delivers a multi-metric leap in quality that helps silicon carbide device manufacturers achieve better yield Wolfspeed, Inc. (NYSE:WOLF), a global leader in silicon carbide (SiC) technology, today announced the commercial availability of its new Premium 200 mm n-type silicon carbide substrate, expanding its 200 mm SiC materials portfolio with a higher-quality starting material designed to improve yield through reduced defects and greater wafer-shape stability. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260927368960/en/Wolfspeed expands 200 mm portfolio with premium substrate As the SiC devices industry pus

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM), a leading rare disease company, today announced that it will host an investor call on Monday, September 28, 2026 at 8:30 a.m. ET/5:30 a.m. PT to share topline results from the Phase 3 AZURE-1 study of brelovitug in chronic hepatitis delta virus (HDV), along with 48-week data from the Phase 2b portion of the study.Conference Call Details:US/Toll-Free: +1 833 461 5787International: +1 585 542 9983Access Code: 979912911You may also access the call via webcast by visiting the Investors section of Mirum’s corporate website. The archived webcast will be available for replay.About Mirum PharmaceuticalsMirum Pharmaceuticals (NASDAQ:MIRM) is a leading rare d

Participants from all 50 states and 52 countries hit the pavement on Chicago's Southside for 29th annual eventBy the NumbersNearly 10,000 participants50 states represented52 countries representedNearly 45% running their first-ever half marathon or 5K1,000+ participants running alongside a family memberAges 2 to 88 represented across the event29th annual eventCHICAGO, Sept. 27, 2026 /PRNewswire/ -- Nearly 10,000 runners from across the country and around the world took to Chicago's South Side Sunday for the sold-out Life Time Chicago Half Marathon & 5K, with nearly half of participants competing in their first-ever half marathon or 5K — offering a snapshot of how the sport continues to welcom

Following a patriotic Newport Harbor send-off with more than 60 of the area’s finest sportfishing vessels, veterans begin three days of fishing, healing and connection with Southern California’s sportfishing community First-ever WHOW Cars & Coffee fundraiser kicked off a day of community support 2026 event is the largest fundraising year in WHOW history 130 combat-wounded veterans embarked on a meaningful sportfishing journey as they set out from Newport Harbor Saturday evening to participate in the ninth annual War Heroes on Water (WHOW) sportfishing tournament, presented by loanDepot. Supported by a fleet of more than 60 yachts and the dedicated owners, captains and crews who make t

MADISON, Wis., Sept. 27, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ:ARAY) today announced that it had entered into agreements with Samsung HME America, Inc., dba NeuroLogica Corp. ("Samsung NeuroLogica") to pursue advanced volumetric imaging capabilities for the CyberKnife® System. The announcement coincides with the American Society of Radiation Oncology (ASTRO) Annual Meeting in Boston, Massachusetts, where the companies are highlighting their collaboration. The collaboration represents another example of Accuray's strategy to address customer priorities through targeted partnerships that bring together complementary expertise.

Singapore, Sept. 26, 2026 (GLOBE NEWSWIRE) -- Platinum Analytics Cayman Limited (the "Company" or "PLTS"), a software developer specializing in the provision of FX trading software development solutions, data analytics solutions and technology development solutions to financial institutions with a strategic focus on serving Asia and other emergent markets, today announced that on September 21, 2026, it received a notice from The Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that the Nasdaq Hearings Panel (the "Panel") had denied the Company’s request to reinstate trading on Nasdaq and determined to delist the Company’s securities (the "Panel Decision").     As previously discl

Drawing from Wrangler's iconic archive, the collection is reimagined through imogene + willie's distinctly American approach to craftsmanship and making. For more than 75 years, Wrangler® has helped define American denim. For imogene + willie, that legacy has been a source of inspiration and admiration since its founding in 2009. Built on a shared reverence for the craft and heritage of American denim, the two brands have partnered on a landmark collection that pairs Wrangler's defining place in denim history with imogene + willie's enduring commitment to domestic manufacturing. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/202